Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer;Cardiovascular;Adverse Events”

264 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 264 results

Not applicableLooking for participantsNCT06100328
What this trial is testing

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)

Who this might be right for
Cardiac Tumor
First Affiliated Hospital Xi'an Jiaotong University 40
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Not applicableActive Not RecruitingNCT07442578
What this trial is testing

Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial

Who this might be right for
Childhood Cancer SurvivorsCardiotoxicityCardiovascular Diseases+1 more
Dana-Farber Cancer Institute 20
Not applicableUnknownNCT05996276
What this trial is testing

Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION)

Who this might be right for
Esophagus Cancer
University Hospital, Brest 150
Not applicableUnknownNCT04461392
What this trial is testing

Exercise Response After Revalidation in Cancer Patients

Who this might be right for
OncologyCardiac Toxicity
Universitair Ziekenhuis Brussel 191
Not applicableLooking for participantsNCT07058454
What this trial is testing

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

Who this might be right for
Cancer;Cardiovascular;Adverse EventsCancer
Sixth Affiliated Hospital, Sun Yat-sen University 5,000
Not applicableLooking for participantsNCT05023785
What this trial is testing

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

Who this might be right for
Heart FailureCardiotoxicityCancer
University Health Network, Toronto 336
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Not applicableStudy completedNCT05130489
What this trial is testing

CAR T Cell Therapy Related Cardiovascular Outcomes

Who this might be right for
Cardiovascular DiseasesB-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma Refractory+5 more
University College London Hospitals 150
Not applicableStudy completedNCT03940625
What this trial is testing

Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping

Who this might be right for
Breast CancerMyocardial DamageCardiotoxicity
Heinrich-Heine University, Duesseldorf 69
Testing effectiveness (Phase 2)Study completedNCT06888505
What this trial is testing

Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Who this might be right for
Anthracyclines-Induced CardiotoxicityCardiotoxicity
Hawler Medical University 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221
What this trial is testing

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Anthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more
Shiraz University of Medical Sciences 400
Post-approval studies (Phase 4)Study completedNCT02696707
What this trial is testing

An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 200
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableStudy completedNCT07515859
What this trial is testing

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Who this might be right for
Cancer Therapy-Related Cardiac DysfunctionHeart FailureLeft Ventricular Dysfunction
Yonsei University 31,486
Not applicableLooking for participantsNCT06726590
What this trial is testing

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Who this might be right for
DiabetesCholesterolCancer+6 more
Texas A&M University 3,000
Testing effectiveness (Phase 2)Study completedNCT01009918
What this trial is testing

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Who this might be right for
Breast CancerCardiac Toxicity
University of South Florida 468
Not applicableLooking for participantsNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Not applicableUnknownNCT04877899
What this trial is testing

Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol

Who this might be right for
CardiotoxicityCancer
Ultromics Ltd 250
Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Load More Results